Literature DB >> 19027350

Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV.

Elizabeth Andrews1, William T Seaman, Jennifer Webster-Cyriaque.   

Abstract

Incidence of oropharyngeal squamous cell carcinoma (OSCC) increased 3% annually from 1973 to 2001. OSCC's can be attributed to tobacco and alcohol, but 25% are unlinked to typical risks. Case-control studies on HPV detection in non-smoking/non-drinking (NS/ND) OSCC patients have not previously been performed. The primary objective of this study was to determine whether high-risk HPV infection was significantly associated with development of oral squamous malignancy in non-smokers/non-drinkers. A chart review of 802 OSCC patients from the UNC Pathology Archives (1995-2006) yielded 40 non-smoker/non-drinker subjects. Utilizing a case-control design, 18 cancer cases and 22 benign biopsy controls were consecutively identified. Biopsy tissue was subjected to (i) HPV-L1 consensus PCR and sequencing (ii) real-time PCR. Chi-square and logistic regression analysis was employed. Logistic regression analysis determined that cases were 6.1 (OR 95% CI, 1.3-28) times more likely to have HPV infection in their tumors than controls. High-risk HPV-DNA was readily detected in the tonsils and base of tongue (oropharynx) of 14/18 cases and 6/22 controls by both consensus and real-time PCR. Of high-risk HPV containing lesions, 85% (17/20) originated in the oropharynx (chi-square, p=0.03). High risk HPV was also detected in benign biopsies of the oropharynx in 30% (3/10) of individuals who had a previous oral cancer (chi-square, p=0.006). The infectious nature of OSCC in NS/ND was revealed by consistent detection of HPV, suggesting HPV's potential role in transforming oral epithelium, providing further evidence of the need to screen the oropharynx for HPV in NS/ND.

Entities:  

Mesh:

Year:  2008        PMID: 19027350     DOI: 10.1016/j.oraloncology.2008.07.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  40 in total

Review 1.  Saliva as a diagnostic fluid.

Authors:  Daniel Malamud
Journal:  Dent Clin North Am       Date:  2011-01

Review 2.  Deciphering the cells of origin of squamous cell carcinomas.

Authors:  Adriana Sánchez-Danés; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 3.  Overview of the oral HIV/AIDS Research Alliance Program.

Authors:  C H Shiboski; J Y Webster-Cyriaque; M Ghannoum; J S Greenspan; D Dittmer
Journal:  Adv Dent Res       Date:  2011-04

4.  Oral Cavity and Oropharyngeal Cancer: Changing Trends in Incidence in the United States and Oklahoma.

Authors:  Lindsay Denson; Amanda E Janitz; Lacy S Brame; Janis E Campbell
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

5.  Human papillomaviruses as therapeutic targets in human cancer.

Authors:  Karin Hellner; Karl Münger
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 6.  Detecting viruses by using salivary diagnostics.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

Review 7.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

8.  Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.

Authors:  William T Seaman; Elizabeth Andrews; Marion Couch; Erna M Kojic; Susan Cu-Uvin; Joel Palefsky; Allison M Deal; Jennifer Webster-Cyriaque
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

Review 9.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

10.  Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy.

Authors:  Gideon Y Bachar; Christopher Goh; David P Goldstein; Brian O'Sullivan; Jonathan C Irish
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.